tiprankstipranks
Trending News
More News >
Adhera Therapeutics (ATRX)
OTHER OTC:ATRX
US Market

Adhera Therapeutics (ATRX) Income Statement

Compare
13 Followers

Adhera Therapeutics Income Statement

Last quarter (Q3 2023), Adhera Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Adhera Therapeutics's net income was $-3.54M. See Adhera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 252.00K$ 76.19K
Gross Profit
$ 0.00$ 0.00$ 0.00$ -157.00K$ -382.52K
Operating Expenses
$ 1.62M$ 674.00K$ 2.04M$ 11.16M$ 10.24M
Depreciation and Amortization
$ 1.62M$ 674.00K$ 0.00$ 82.00K$ 332.99K
EBITDA
$ 0.00$ 0.00$ -1.99M$ -11.23M$ -16.27M
Operating Income
$ -1.62M$ -674.00K$ -2.04M$ -11.32M$ -15.79M
Other Income/Expenses
$ -496.00K$ -5.68M$ -1.73M$ -662.00K$ -959.96K
Pretax Income
$ -2.11M$ -6.35M$ -3.77M$ -11.98M$ -16.75M
Net Income
$ -2.11M$ -6.35M$ -3.77M$ -11.98M$ -16.75M
Per Share Metrics
Basic EPS
$ -1.18$ -12.84$ -9.80$ -24.80$ -30.92
Diluted EPS
$ -1.18$ -12.84$ -9.80$ -24.80$ -30.92
Weighted Average Shares Outstanding
2.31M 650.18K 543.83K 542.04K 541.94K
Weighted Average Shares Outstanding (Diluted)
2.31M 650.18K 543.83K 542.04K 541.94K
Currency in USD

Adhera Therapeutics Earnings and Revenue History